Demant A/S (OTCMKTS:WILYY) Hits New 1-Year High – Should You Buy?

Demant A/S Unsponsored ADR (OTCMKTS:WILYY – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday. The company traded as high as $28.95 and last traded at $28.95, with a volume of 100 shares traded. The stock had previously closed at $26.60.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on WILYY shares. Sanford C. Bernstein downgraded Demant A/S from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 17th. Zacks Research downgraded Demant A/S from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 12th. Finally, UBS Group lowered shares of Demant A/S from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Analysis on Demant A/S

Demant A/S Stock Performance

The firm’s fifty day moving average is $24.84 and its 200 day moving average is $19.52.

Demant A/S Company Profile

(Get Free Report)

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss and related communication needs. Its business includes hearing aids, hearing implants, audiological diagnostic equipment, and software and technology used by hearing care professionals.

The company’s principal hearing aid brands include Oticon and Bernafon, while its portfolio also includes Philips Hearing Solutions products developed through its partnership with Koninklijke Philips.

Recommended Stories

Receive News & Ratings for Demant A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Demant A/S and related companies with MarketBeat.com's FREE daily email newsletter.